alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of State

          - [Public Notice: 12187]

# SUMMARY:

                        Notice is hereby given of the following determinations: I hereby determine that certain objects being imported from abroad pursuant to agreements with their foreign owners or custodians for temporary display in the exhibition “Lineages: Korean Art at The Met” at The Metropolitan Museum of Art, New York, New York, and at possible additional exhibitions or venues yet to be determined, are of cultural significance, and, further, that their temporary exhibition or display within the United States as aforementioned is in the national interest. I have ordered that Public Notice of these determinations be published in the                         **Federal Register**                        .                    

# FOR FURTHER INFORMATION CONTACT:

                        Reed Liriano, Program Coordinator, Office of the Legal Adviser, U.S. Department of State (telephone: 202-632-6471; email:                         *section2459@state.gov*). The mailing address is U.S. Department of State, L/PD, 2200 C Street NW (SA-5), Suite 5H03, Washington, DC 20522-0505.                    

# SUPPLEMENTARY INFORMATION:

                    The foregoing determinations were made pursuant to the authority vested in me by the Act of October 19, 1965 (79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 Stat. 2681,                     *et seq.;*22 U.S.C. 6501 note,                     *et seq.*), Delegation of Authority No. 234 of October 1, 1999, Delegation of Authority No. 236-3 of August 28, 2000, and Delegation of Authority No. 523 of December 22, 2021.                

Nicole L. Elkon,

Deputy Assistant Secretary for Professional and Cultural Exchanges, Bureau of Educational and Cultural Affairs, Department of State.

[FR Doc. 2023-20430 Filed 9-20-23; 8:45 am]

BILLING CODE 4710-05-P
---

CERTIFICATION OFCHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
  PURSUANT TO18 U.S.C. SECTION 1350,
  AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Daniel Hunter, the Chief Executive Officer and Chief Financial
  Officer of Encore Clean Energy, Inc. (the "Company"), hereby certify pursuant
  to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
  Act of 2002, that, to the best of my knowledge:

| | (i)  | the Quarterly Report on Form 10-QSB of the Company,
        for the fiscal quarter ended June 30, 2004, and to which this certification
        is attached as Exhibit 32.1 (the "Report") fully complies with the requirements
        of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
        and
| | ---- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
| | (ii) | the information contained in the Report fairly presents,
        in all material respects, the financial condition and results of operations
        of the Company.                                                                                                                                                             
|

| | By:    | /s/ Daniel Hunter                
| | ------ | ---------------------------------
| |        |                                  
| | Name:  | DANIEL HUNTER                    
| | Title: | Chief Executive Officer and Chief
| |        | Financial Officer                
| | Date:  | August 12, 2004                  

A signed original of this written statement required by
  Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company
  and will be retained by the Company and furnished to the Securities and Exchange
  Commission or its staff upon request.

This certification accompanies the Form 10-QSB to which
  it relates, is not deemed filed with the Securities and Exchange Commission
  and is not to be incorporated by reference into any filing of the Company under
  the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made
  before or after the date of the Form 10-QSB), irrespective of any general incorporation
  language contained in such filing.

---
CATERPILLAR FINANCIAL SERVICES CORPORATION

POWERNOTES (SM)

With Maturities of 9 months or more from Date of Issue

 

Registration No.  333-59540

Filed Pursuant to Rule 424 (b) (3)

PRICING SUPPLEMENT NO.  222				Trade Date: 09/19/02
(To Prospectus Supplement & Prospectus dated

  June 1, 2001)							Issue Date:  09/24/02
The Date of this Pricing Supplement September 19, 2002
SUBJECT TO REDEMPTION OR REPAYMENT

  CUSIP									Date and terms of redemption or

     or	Stated				             Interest			repayment (including any

Common	Interest		  Price to	 Discounts &         Payment	Survivors		applicable regular or special

  Code	Rate (1)	Maturity	Public (2)	Commissions       Frequency	  Option	Yes/No	record dates)

14911QKF7   2.50%	09/15/04	     100%	        0.5%                Semi Annually	     YES	    NO	

Principal						1st Payment	Day	

Amount		Proceeds		Dealer		      Date		Count

$2,912,000.00	$2,897,440.00	ABN AMRO Inc.	   03/15/03		30/360	
 

Original Issue Discount Note:					Total Amount of OID:

____  Yes	  X   No						N/A

 

 
- The interest rates on the PowerNotes (SM) may be changed by Caterpillar Financial Services Corporation from time to time, but any such change will not affect the interest rate on any PowerNotes (SM) offered prior to the effective date of the change.   Prior to the date of this Pricing Supplement, $711.994 mm principal amount of the PowerNotes (SM) were sold at interest rates then in effect.  Subsequent offerings of PowerNotes (SM) will be made under a Prospectus Supplement and Prospectus dated June 1, 2001.
Additionally, the total principal amount of PowerNotes(SM) offered by Caterpillar Financial Services Corporation pursuant to its Prospectus Supplement and Prospectus dated June 1, 2001 has been increased from $500.0mm to $750.0mm.  $250.0mm principal amount of debt securities registered pursuant to Registration Statement No. 333-59540 originally offered by Caterpillar Financial Services Corporation pursuant to its Prospectus Supplement dated June 15, 2001 and related Prospectus dated May 25, 2001 are being offered as PowerNotes(SM) by Caterpillar Financial Services Corporation pursuant to its Prospectus Supplement and Prospectus dated June 1, 2001.
- Expressed as a percentage of aggregate principal amount.  Actual Price to Public may be less, and will be determined by prevailing market prices at the time of purchase as set forth in the confirmation sheet.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED (A) THE
CONSOLIDATED BALANCE SHEETS AND THE CONSOLIDATED STATEMENTS OF OPERATIONS
FOUND ON PAGE 35 AND 36 OF THE FORM 10-K AS FILED WITH THE SECURITIES AND
EXCHANGE COMMISSION ON DECEMBER 29, 1998 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH (B) FINANCIAL STATEMENTS
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          SEP-30-1999
<PERIOD-START>                             OCT-01-1998
<PERIOD-END>                               MAR-31-1999
<CASH>                                          13,098
<SECURITIES>                                    49,280
<RECEIVABLES>                                    8,133
<ALLOWANCES>                                       153
<INVENTORY>                                          0
<CURRENT-ASSETS>                                73,789
<PP&E>                                           7,557
<DEPRECIATION>                                   3,553
<TOTAL-ASSETS>                                  77,793
<CURRENT-LIABILITIES>                           14,536
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        71,606
<OTHER-SE>                                       8,349
<TOTAL-LIABILITY-AND-EQUITY>                    77,793
<SALES>                                         18,292
<TOTAL-REVENUES>                                23,452
<CGS>                                            1,167
<TOTAL-COSTS>                                   22,678
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  23
<INCOME-PRETAX>                                  2,482
<INCOME-TAX>                                     (885)
<INCOME-CONTINUING>                              3,367
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,367
<EPS-PRIMARY>                                     0.21
<EPS-DILUTED>                                     0.20
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          APR-30-2001
<PERIOD-END>                               JUL-31-2000
<CASH>                                         135,185
<SECURITIES>                                         0
<RECEIVABLES>                                  417,180
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               552,365
<PP&E>                                      16,123,826
<DEPRECIATION>                               (473,513)
<TOTAL-ASSETS>                              16,664,590
<CURRENT-LIABILITIES>                        9,341,833
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                     50,000
<COMMON>                                     2,384,434
<OTHER-SE>                                  16,963,391
<TOTAL-LIABILITY-AND-EQUITY>                 7,322,757
<SALES>                                        374,148
<TOTAL-REVENUES>                               374,178
<CGS>                                                0
<TOTAL-COSTS>                                1,104,726
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             186,111
<INCOME-PRETAX>                              (916,659)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (916,659)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (916,659)
<EPS-BASIC>                                     (0.04)
<EPS-DILUTED>                                   (0.04)


</TABLE>
EXHIBIT 32.1
                            CERTIFICATION PURSUANT TO
                 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned Richard Starke, President of Lotus Capital Corp. hereby
certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:

(1) the annual report on Form 10-KSB of Lotus Capital Corp. for the year ended
December 31, 2004 (the "Report") fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of Lotus Capital
Corp.


 Dated: April 11, 2005


 /s/ Richard Starke
 ------------------
 Richard Starke
 President
 (Principal Executive Officer)
Here's how you know
 **Official websites use .mil** .mil
 **Secure .mil websites use HTTPS** lock () https://


Skip to main content (Press Enter).
 Toggle navigation
            
            U.S. Central Command
                CENTCOM
        Search
                    Search CENTCOM:
                        Search
                Search CENTCOM:
                    Search
    Home

    ABOUT US
    
        COMMAND PRIORITIES

    LEADERSHIP

    COMPONENT COMMANDS

    HISTORY

    POSTURE STATEMENT

    CENTCOM AOR
    
        CENTCOM COALITION

    OPERATIONS AND EXERCISES
    
        USMTM

    CIVILIAN CASUALTY REPORT

    CONTACT
    
        OPERATIONAL CONTRACT SUPPORT

    COMMUNITY RELATIONS

    THEATRE MEDICAL CLEARANCE

    INNOVATION VENDOR PORTAL

    MILITARY MEMBER INNOVATION PORTAL

    MEDIA
    
        SOCIAL MEDIA

    NEWS ARTICLES

    PRESS RELEASES

    STATEMENTS

    IMAGERY

    VIDEOS

    TRANSCRIPTS

    VISITORS AND PERSONNEL
    
        FAMILY CENTER

    FAMILY READINESS

    CENTCOM WEBMAIL

    SOCIAL MEDIA SECURITY

    ACCOUNTABILITY

    EMERGENCY PREPAREDNESS

    USCENTCOM UNCLASSIFIED REGULATIONS

    FOIA LIBRARY

    INNOVATION OASIS

    WELCOME GUIDE  Search
 Search
 All Images All ImagesCommunity RelationsOtherPreviousCommanders
 Upload Date Upload DatePhoto DateTitle
  Share
  
 Small () Medium () Full Size (2.17 MB)
 
 5th Fleet NAVSUP NAVSUP FLC Bahrain
 Photo Gallery
 About UsCommand PrioritiesLeadershipComponent
   CommandsHistoryPosture Statement
   Area of
   ResponsibilityCENTCOM Coalition
   Operations And
   ExercisesOperation Inherent
   ResolveResolute Support
   MediaSocial MediaNews ArticlesPress ReleasesVideo And Imagery
   Visitors And
   PersonnelFamily ReadinessCENTCOM WebmailSocial MediaSecurityAccountabilityEmergency
   Preparedness
   ContactCommunity Relations
                    Stay Connected
                
                Privacy & Security  Inspector General  FOIA  Privacy Act
            

Hosted by Defense Media Activity - WEB.mil
Amendment No. 2 to Employment Agreement with Mark Wood



 Exhibit 10.7 
 AMENDMENT NO. 2 TO 
 EMPLOYMENT AGREEMENT 

THIS AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (the “Amendment”) made as of December 17, 2012 (“Effective
Date”) by and between BioMarin Pharmaceutical Inc., a Delaware corporation (the “Company”) and Mark Wood (“Employee”). 
  

	1.	This Amendment No. 2 is intended to amend and modify that certain Employment Agreement by and between the Company and Employee dated January 1, 2009 and amended on May
8, 2012 (the “Agreement”). The Agreement, together with this Amendment, shall constitute a single agreement. Capitalized terms not otherwise defined in this Amendment shall have the meaning ascribed to such terms in the Agreement.
Except as expressly modified by this Amendment, the Agreement shall remaining full force and effect according to its terms. 

  

	2.	The defined term “Termination Compensation,” as provided in Section 7(c) of the Agreement, is hereby deleted and replaced in its entirety by the
following definition: 

 Termination Compensation. For purposes of this Agreement, the term
“Termination Compensation” shall mean: (i) one hundred forty percent (140%) of the Employee’s then current annual base salary which shall be payable in a lump sum within forty-five (45) days after separation of employment, conditioned
on Employee executing the Company’s standard form severance and release agreement within twenty (20) days of the Employee’s termination, and shall be subject to customary withholding and other applicable payroll processes. If Employee
fails to execute and deliver the Company’s standard form severance and release agreement within twenty (20) days after the Employee’s termination, Employee will have no right to any Termination Compensation under this Agreement.

  

	3.	This Amendment No. 2 may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the
same instrument. 

 IN WITNESS WHEREOF, the parties to this Amendment have executed this Amendment as of the date
first written above. 
  

									
	BIOMARIN PHARMACEUTICAL INC.	  		  	EMPLOYEE
					
	By:	 	 /s/ Jean-Jacques Bienaimé
	  		  	By:	 	 /s/ Mark Wood

	Name: Jean-Jacques Bienaimé	  		  		 	Mark Wood
	Its:      Chief Executive Officer
UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549





Form 8-K





Current Report





Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934





Date of Report  (Date of earliest event reported): January 28, 2013





Caterpillar Financial Services Corporation


(Exact name of Registrant as specified in its charter)





001-11241


(Commission File Number)





Delaware37-1105865(State or other jurisdiction of incorporation)(IRS Employer Identification Number)





2120 West End Avenue


Nashville, Tennessee 37203-0001


(Address of principal executive offices, with zip code)





(615) 341-1000


(Registrant's telephone number, including area code)








Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:





oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




---




Item 2.02. Results of Operations and Financial Condition.





On January 28, 2013, Caterpillar Financial Services Corporation issued a press release reporting financial results for the year and fourth quarter ended December 31, 2012.  A copy of the press release is attached hereto as Exhibit 99.1 and incorporated into this Item 2.02 by reference.





The information in this Current Report on Form 8-K, including Exhibit 99.1, is being furnished in accordance with the provisions of General Instruction B.2 of Form 8-K.








Item 9.01.  Financial Statements and Exhibits.





d)Exhibits:99.1Caterpillar Financial Services Corporation press release dated January 28, 2013








SIGNATURES





Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.





Caterpillar Financial Services Corporation








Date:  January 28, 2013By:/s/ J. Wesley BlumenshineJ. Wesley BlumenshineSecretary





2


---




EXHIBIT INDEX





Exhibit No.Description99.1Caterpillar Financial Services Corporation press release dated January 28, 2013














3
From: jpierce@fpcboulder.org

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 12:37:02 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Judy Pierce

Louisville, CO 80027
United States Court of Appeals

FOR THE DISTRICT OF COLUMBIA CIRCUIT

____________

No. 10-3017 September Term 2011

1:08-cr-00344-EGS-1

Filed On: April 11, 2012

United States of America,

Appellee

v.

Jesus Rodriguez,

Appellant

BEFORE: Henderson, Circuit Judge, and Williams and Ginsburg, Senior

Circuit Judges

O R D E R

Upon consideration of the court’s order to show cause filed March 9, 2012,

and the response thereto, it is

ORDERED that the order to show cause be discharged. It is

FURTHER ORDERED that the sealed opinion filed March 9, 2012, be

unsealed. The Clerk is directed to unseal the opinion and release it publicly.

Per Curiam

FOR THE COURT:

Mark J. Langer, Clerk 

BY: /s/

Jennifer M. Clark 

Deputy Clerk
##### 



EXHIBIT 99.2

Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant To
Section 906 of the Sarbanes-Oxley Act of 2002

I, John L. Coker, Vice President, Finance and Administration and Chief
Financial Officer of BioReliance Corporation (the Corporation), certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1350,
that:

(1)  the Quarterly Report on Form 10-Q of the Corporation for the period
ended September 30, 2002, as filed with the Securities and Exchange Commission
on the date hereof (the Report), fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)  the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Corporation.

/s/ John L. Coker

John L. Coker
Vice President, Finance and Administration
and Chief Financial Officer
November 14, 2002